Bristol Myers: EMA submission for colorectal cancer : compar

Bristol Myers Squibb announces that the European Medicines Agency has validated its application for Opdivo + Yervoy as first-line treatment for adult patients with metastatic colorectal cancer with...

Related Keywords

Bristol Myers Squibb , Dana Walker , European Medicines Agency , Global Head , Genitourinary Cancers , Bristol Myers , Markets ,